{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:29:26Z","timestamp":1766399366303,"version":"3.41.2"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"Background<\/jats:title>At present, the knowledge about disease-causing mutations in IRF2BP2 is very limited because only a few patients affected by this condition have been reported. As previous studies have described, the haploinsufficiency of this interferon transcriptional corepressors leads to the development of CVID. Very recently, a more accurate phenotype produced by truncating variants in this gene has been defined, manifesting CVID with gastrointestinal inflammatory symptoms and autoimmune manifestations.<\/jats:p><\/jats:sec>Methods<\/jats:title>We analyzed 5 index cases with suspected primary immunodeficiency by high throughput sequencing. They were submitted for a genetic test with a panel of genes associated with immune system diseases, including IRF2BP2. The screening of SNVs, indels and CNVs fulfilling the criteria with very low allelic frequency and high protein impact, revealed five novel variants in IRF2BP2. In addition, we isolated both wild-type and mutated allele of the cDNA from one of the families.<\/jats:p><\/jats:sec>Results<\/jats:title>In this study, we report five novel loss-of-function (LoF) mutations in IRF2BP2 that likely cause primary immunodeficiency, with CVID as more frequent phenotype, variable expression of inflammatory gastrointestinal features, and one patient with predisposition of viral infection. All identified variants were frameshift changes, and one of them was a large deletion located on chromosome 1q42, which includes the whole sequence of IRF2BP2, among other genes. Both de novo<\/jats:italic> and dominant modes of inheritance were observed in the families here presented, as well as incomplete penetrance.<\/jats:p><\/jats:sec>Conclusions<\/jats:title>We describe novel variants in a delimited low-complex region, which may be considered a hotspot in IRF2BP2. Moreover, this is the first time that a large CNV in IRF2BP2 has been reported to cause CVID. The distinct mechanisms than LoF in IRF2BP2 could cause different phenotype compared with the mainly described. Further investigations are necessary to comprehend the regulatory mechanisms of IRF2BP2, which could be under variable expression of the disease.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1279171","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T14:09:14Z","timestamp":1696860554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel frameshift variants expand the map of the genetic defects in IRF2BP2"],"prefix":"10.3389","volume":"14","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Garc\u00eda-Aznar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Maneiro Pamp\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Garc\u00eda Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Acu\u00f1a P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Paz Gandiaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Minguell Domingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Calavia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pere","family":"Soler-Palacin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Colobran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika M.","family":"Novoa Bol\u00edvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Gonzalo","family":"Ocejo Vinyals","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkg431","article-title":"Identification of novel co-repressor molecules for Interferon Regulatory Factor-2","volume":"31","author":"Childs","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.2A0815-368R","article-title":"IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering","volume":"100","author":"S\u00e9cca","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.655307","article-title":"The transcriptional co-factor IRF2BP2: A new player in tumor development and microenvironment","volume":"9","author":"Pastor","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00974-10","article-title":"Interferon regulatory factor 2 binding protein 2 is a new NFAT1 partner and represses its transcriptional activity","volume":"31","author":"Carneiro","year":"2011","journal-title":"Mol Cell Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1096\/fj.10-167049","article-title":"IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression","volume":"24","author":"Teng","year":"2010","journal-title":"FASEB J"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080797","article-title":"IRF2BP2 mutation is associated with increased STAT1 and STAT5 activation in two family members with inflammatory conditions and lymphopenia","volume":"14","author":"Palmroth","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.115.307245","article-title":"IRF2BP2: A new player at the crossroads of inflammation and lipid metabolism","volume":"117","author":"Zhang","year":"2015","journal-title":"Circ Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2019.52.7.104","article-title":"The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation","volume":"52","author":"Kim","year":"2019","journal-title":"BMB Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1146\/annurev-pathmechdis-031521-024229","article-title":"Common variable immunodeficiency: more pathways than roads to Rome","volume":"18","author":"Peng","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.01.018","article-title":"Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder","volume":"138","author":"Keller","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2021.04.005","article-title":"Molecular diagnosis of childhood immune dysregulation, polyendocrinopathy, and enteropathy, and implications for clinical management","volume":"149","author":"Baxter","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac575","article-title":"Novel mutation and expanding phenotype in IRF2BP2 deficiency","volume":"62","author":"K\u00f6rholz","year":"2023","journal-title":"Rheumatol (Oxford)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.967345","article-title":"Case Report: A novel IRF2BP2 mutation in an IEI patient with recurrent infections and autoimmune disorders","volume":"14","author":"Pan","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1261\/rna.2401811","article-title":"Mechanism of escape from nonsense-mediated mRNA decay of human beta-globin transcripts with nonsense mutations in the first exon","volume":"17","author":"Neu-Yilik","year":"2011","journal-title":"RNA"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2019.105382","article-title":"IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling","volume":"192","author":"Manjur","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.6004\/jnccn.2015.0005","article-title":"Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia","volume":"13","author":"Yin","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI98164","article-title":"Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency","volume":"128","author":"Boutboul","year":"2018","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00930-3","article-title":"Inherited GATA2 deficiency is dominant by haploinsufficiency and displays incomplete clinical penetrance","volume":"41","author":"Oleaga-Quintas","year":"2021","journal-title":"J Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1279171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T14:09:16Z","timestamp":1696860556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1279171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":19,"alternative-id":["10.3389\/fimmu.2023.1279171"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1279171","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"article-number":"1279171"}}